ARMO Biosciences | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (15)

View All

Latest Posts

About This Stock More About This Stock
Week In Review: $3.4 Billion Week For China Life Science Deals
Article By: ChinaBio® Today
Saturday, May 12, 2018 4:50 PM EDT
Armo Biosciences, a Bay Area immuno-oncology company, agreed to be acquired by Eli Lilly. Lilly offered to pay $50 per share for Armo, a three-fold increase from the IPO price and a 67% jump from its previous close.
In this article: AZN, LLY, ARMO, GILD
Read
Week In Review: Luye May Stage $500 Million Singapore IPO Of Healthcare Assets
Article By: ChinaBio® Today
Saturday, January 27, 2018 3:39 PM EDT
Luye Medical, the healthcare arm of Luye Life Sciences, is considering an IPO in Singapore that could raise as much as $500 million (see story). The company has assembled a portfolio of businesses, largely through M&A.
In this article: GSK, PFE, ARMO
Read
All Posts

Latest Tweets for $ARMO

No tweets yet!

PARTNER HEADLINES